Gsk Plc
No standout activity across the feeds we track.
Stocks scoring 25–45 beat the S&P 500 45.3% of the time over the next three months, since 2015. How we measured this →
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis,…
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2025-10-31 | Lisa C. McClain · R-MI | House | Sold | $1,001 - $15,000 |
| 2025-10-30 | Lisa C. McClain · R-MI | House | Bought | $1,001 - $15,000 |
| 2025-10-30 | Lisa C. McClain · R-MI | House | Sold | $1,001 - $15,000 |
| 2025-09-23 | Val T. Hoyle · D-OR | House | Sold | $1,001 - $15,000 |
| 2025-08-04 | Lisa C. McClain · R-MI | House | Bought | $1,001 - $15,000 |
| 2025-07-28 | Robert B. Aderholt · R-AL | House | Sold | $1,001 - $15,000 |
| 2025-06-24 | Lisa C. McClain · R-MI | House | Sold | $1,001 - $15,000 |
| 2025-06-17 | Lisa C. McClain · R-MI | House | Bought | $1,001 - $15,000 |
| 2025-04-21 | Bruce Westerman · R-AR | House | Sold | $1,001 - $15,000 |
| 2025-03-03 | Bruce Westerman · R-AR | House | Bought | $1,001 - $15,000 |
Show the other 29
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2024-11-25 | Marjorie Taylor Greene · R-GA | House | Bought | $1,001 - $15,000 |
| 2024-11-18 | Val T. Hoyle · D-OR | House | Bought | $1,001 - $15,000 |
| 2023-07-10 | Daniel S. Goldman · D-NY | House | Sold | $15,001 - $50,000 |
| 2023-03-01 | Virginia Foxx · R-NC | House | Sold | $50,001 - $100,000 |
| 2022-08-16 | Virginia Foxx · R-NC | House | Bought | $1,001 - $15,000 |
| 2022-08-10 | Virginia Foxx · R-NC | House | Bought | $15,001 - $50,000 |
| 2022-08-09 | Virginia Foxx · R-NC | House | Bought | $1,001 - $15,000 |
| 2022-08-05 | Virginia Foxx · R-NC | House | Bought | $15,001 - $50,000 |
| 2022-07-12 | Virginia Foxx · R-NC | House | Sold | $100,001 - $250,000 |
| 2022-07-06 | Virginia Foxx · R-NC | House | Bought | $1,001 - $15,000 |
| 2022-04-08 | Virginia Foxx · R-NC | House | Bought | $1,001 - $15,000 |
| 2022-02-22 | Virginia Foxx · R-NC | House | Bought | $1,001 - $15,000 |
| 2022-02-17 | John H. Rutherford · R-FL | House | Sold | $1,001 - $15,000 |
| 2022-01-14 | Virginia Foxx · R-NC | House | Bought | $1,001 - $15,000 |
| 2021-10-08 | Virginia Foxx · R-NC | House | Bought | $1,001 - $15,000 |
| 2021-07-09 | Virginia Foxx · R-NC | House | Bought | $1,001 - $15,000 |
| 2021-06-04 | Katherine M. Clark · D-MA | House | Sold | $1,001 - $15,000 |
| 2021-04-09 | Virginia Foxx · R-NC | House | Bought | $1,001 - $15,000 |
| 2021-01-15 | Virginia Foxx · R-NC | House | Bought | $1,001 - $15,000 |
| 2020-11-05 | Katherine M. Clark · D-MA | House | Bought | $1,001 - $15,000 |
| 2020-10-22 | Katherine M. Clark · D-MA | House | Sold | $1,001 - $15,000 |
| 2020-10-09 | Virginia Foxx · R-NC | House | Bought | $1,001 - $15,000 |
| 2020-07-10 | Virginia Foxx · R-NC | House | Bought | $1,001 - $15,000 |
| 2020-04-13 | Virginia Foxx · R-NC | House | Bought | $15,001 - $50,000 |
| 2020-03-18 | Greg Gianforte · R-MT | House | Bought | $50,001 - $100,000 |
| 2020-03-02 | Katherine M. Clark · D-MA | House | Bought | $1,001 - $15,000 |
| 2020-01-10 | Virginia Foxx · R-NC | House | Bought | $1,001 - $15,000 |
| 2017-06-15 | Patty Murray · D-WA | Senate | Sold | $1,001 - $15,000 |
| 2017-03-16 | Patty Murray · D-WA | Senate | Bought | $1,001 - $15,000 |
Markers sit on the transaction date the member disclosed, snapped to the nearest close on the chart. They are not the date the public found out — that came later, and the gap is its own page. Every marker is listed by name in the table above.